369 related articles for article (PubMed ID: 15319169)
1. Serum transforming growth factor-beta1(TGF-beta1) in patients with cirrhosis, chronic hepatitis B and chronic hepatitis C [corrected].
Kirmaz C; Terzioglu E; Topalak O; Bayrak P; Yilmaz O; Ersoz G; Sebik F
Eur Cytokine Netw; 2004; 15(2):112-6. PubMed ID: 15319169
[TBL] [Abstract][Full Text] [Related]
2. Urinary transforming growth factor beta1 levels in hepatitis C virus-related chronic liver disease: correlation between high levels and severity of disease.
Tsai JF; Jeng JE; Chuang LY; Chang WY; Tsai JH
Hepatology; 1997 May; 25(5):1141-6. PubMed ID: 9141431
[TBL] [Abstract][Full Text] [Related]
3. [Level of serum and liver tissue TGF-beta1 in patients with liver fibrosis due to chronic hepatitis B].
Guo JC; Bao JF; Chen QW; Li XO; Shi JP; Lou GQ; Shi WZ; Xun YH
Zhonghua Shi Yan He Lin Chuang Bing Du Xue Za Zhi; 2008 Oct; 22(5):354-7. PubMed ID: 19469173
[TBL] [Abstract][Full Text] [Related]
4. Serum concentration of transforming growth factor (TGF)-beta 1 does not predict advanced liver fibrosis in children with chronic hepatitis B.
Lebensztejn DM; Sobaniec-Lotowska M; Kaczmarski M; Werpachowska I; Sienkiewicz J
Hepatogastroenterology; 2004; 51(55):229-33. PubMed ID: 15011870
[TBL] [Abstract][Full Text] [Related]
5. Plasma transforming growth factor beta1, metalloproteinase-1 and tissue inhibitor of metalloproteinases-1 in acute viral hepatitis type B.
Flisiak R; Jaroszewicz J; Lapiński TW; Flisiak I; Rogalska M; Prokopowicz D
Regul Pept; 2005 Nov; 131(1-3):54-8. PubMed ID: 16081167
[TBL] [Abstract][Full Text] [Related]
6. [The effect of serum TGFb1 of patients with chronic hepatitis B in liver fibrosis formation].
Liu F; Li B; Nan Y
Zhonghua Gan Zang Bing Za Zhi; 1999 Dec; 7(4):196-8. PubMed ID: 10715784
[TBL] [Abstract][Full Text] [Related]
7. Plasma tissue inhibitor of metalloproteinases-1 and transforming growth factor beta 1--possible non-invasive biomarkers of hepatic fibrosis in patients with chronic B and C hepatitis.
Flisiak R; Maxwell P; Prokopowicz D; Timms PM; Panasiuk A
Hepatogastroenterology; 2002; 49(47):1369-72. PubMed ID: 12239944
[TBL] [Abstract][Full Text] [Related]
8. HCV infection in haemodialysed patients: a role for serum IL-10 and TGF-beta1 in liver damage?
Burra P; Masier A; Morisco F; Di Leo V; Zorzi M; Senzolo M; Marchini F; Guido M; Canova D; Floreani A; Burroughs AK
Dig Liver Dis; 2008 Oct; 40(10):827-33. PubMed ID: 18372225
[TBL] [Abstract][Full Text] [Related]
9. Transforming growth factors beta 1 and alpha in chronic liver disease. Effects of interferon alfa therapy.
Castilla A; Prieto J; Fausto N
N Engl J Med; 1991 Apr; 324(14):933-40. PubMed ID: 1900574
[TBL] [Abstract][Full Text] [Related]
10. [Role of the Regulatory T lymphocytes in hepatitis C fibrosis progression].
Delhem N; Cottrez F; Carpentier A; Miroux C; Moralès O; François V; Groux H; Auriault C; Pancré V
Bull Cancer; 2008 Nov; 95(11):1029-38. PubMed ID: 19036674
[TBL] [Abstract][Full Text] [Related]
11. Serum adipokine levels in chronic liver diseases: association of resistin levels with fibrosis severity.
Tsochatzis E; Papatheodoridis GV; Hadziyannis E; Georgiou A; Kafiri G; Tiniakos DG; Manesis EK; Archimandritis AJ
Scand J Gastroenterol; 2008; 43(9):1128-36. PubMed ID: 18609175
[TBL] [Abstract][Full Text] [Related]
12. Hyaluronic acid, transforming growth factor-beta1 and hepatic fibrosis in patients with chronic hepatitis C virus and human immunodeficiency virus co-infection.
Sanvisens A; Serra I; Tural C; Tor J; Ojanguren I; Barluenga E; Rey-Joly C; Clotet B; Muga R
J Viral Hepat; 2009 Jul; 16(7):513-8. PubMed ID: 19200132
[TBL] [Abstract][Full Text] [Related]
13. Serum level of transforming growth factor-beta1 (TGF-beta1) and the expression of TGF-beta receptor type II in peripheral blood mononuclear cells in patients with autoimmune hepatitis.
Sakaguchi K; Kitano M; Nishimura M; Senoh T; Ohta T; Terao M; Shinji N; Koide N; Tsuji T
Hepatogastroenterology; 2004; 51(60):1780-3. PubMed ID: 15532825
[TBL] [Abstract][Full Text] [Related]
14. Serum concentrations of sIL-2R, IL-6, TGF-beta1, neopterin, and zinc in chronic hepatitis C patients treated with interferon-alpha.
Grüngreiff K; Reinhold D; Ansorge S
Cytokine; 1999 Dec; 11(12):1076-80. PubMed ID: 10623433
[TBL] [Abstract][Full Text] [Related]
15. [Effect of polymorphism of transforming growth factor beta1 gene on HBV-induced liver cirrhosis].
Yang ZX; Wang H; Gao CF; Xu LL; Zhao WJ
Zhonghua Yi Xue Za Zhi; 2005 Apr; 85(15):1021-6. PubMed ID: 16029542
[TBL] [Abstract][Full Text] [Related]
16. -509C>T polymorphism in the TGF-beta1 gene promoter, impact on the hepatocellular carcinoma risk in Chinese patients with chronic hepatitis B virus infection.
Qi P; Chen YM; Wang H; Fang M; Ji Q; Zhao YP; Sun XJ; Liu Y; Gao CF
Cancer Immunol Immunother; 2009 Sep; 58(9):1433-40. PubMed ID: 19169878
[TBL] [Abstract][Full Text] [Related]
17. Hepatitis C and liver fibrosis.
Schuppan D; Krebs A; Bauer M; Hahn EG
Cell Death Differ; 2003 Jan; 10 Suppl 1():S59-67. PubMed ID: 12655347
[TBL] [Abstract][Full Text] [Related]
18. [Relationship between serum TGF beta-1 with chronic hepatitis B involving in liver cell function and liver biopsy fibrosis].
Sun Y; Xuan S; Xin Y; Lu W; Chu L
Zhonghua Gan Zang Bing Za Zhi; 2002 Jun; 10(3):221-2. PubMed ID: 12113686
[No Abstract] [Full Text] [Related]
19. Effects of RNA interference targeting transforming growth factor-beta 1 on immune hepatic fibrosis induced by Concanavalin A in mice.
Xu W; Wang LW; Shi JZ; Gong ZJ
Hepatobiliary Pancreat Dis Int; 2009 Jun; 8(3):300-8. PubMed ID: 19502172
[TBL] [Abstract][Full Text] [Related]
20. Evidence for the involvement of TGF-β1-CTGF axis in liver fibrogenesis secondary to hepatic viral infection.
Tache D; Bogdan F; Pisoschi C; Baniţă M; Stănciulescu C; Fusaru AM; Comănescu V
Rom J Morphol Embryol; 2011; 52(1 Suppl):409-12. PubMed ID: 21424084
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
